-
1 Comment
Zhende Medical Co., Ltd is currently in a long term downtrend where the price is trading 26.8% below its 200 day moving average.
From a valuation standpoint, the stock is 85.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.4.
Zhende Medical Co., Ltd's total revenue rose by 721.3% to $4B since the same quarter in the previous year.
Its net income has increased by 3068.5% to $1B since the same quarter in the previous year.
Finally, its free cash flow grew by 221.8% to $166M since the same quarter in the previous year.
Based on the above factors, Zhende Medical Co., Ltd gets an overall score of 4/5.
| Exchange | SHG |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100003J31 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | 5B |
|---|---|
| Target Price | 28 |
| PE Ratio | 14.35 |
| Beta | 0.69 |
| Dividend Yield | None |
Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment in China. It offers stoma and modern wound care products, surgical infection control products, sensory control protection products, infection control protection products, basic wound care products, and pressure therapy and immobilization products, as well as medical-grade personal care and home health care products. The company sells its products approximately in 70 countries and regions in Europe, North America, Asia, South America, Africa, and Oceania. Zhende Medical Co., Ltd. was founded in 1994 and is headquartered in Shaoxing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603301.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
